1 in 4 people will develop Afib, and 1 in 5 people will develop heart failure. Both are conditions that are likely to dominate the next 50 years of cardiovascular care are also increasing in prevalence.

Learn more about the impact of HF and how you can help:

Afib and Heart Failure.

Two conditions that are likely to dominate the next 50 years of cardiovascular care are also increasing in prevalence.

Both affect millions of people and after age 40:

1 in 4 people will develop Afib
1 in 5 people will develop HF

And, regardless of which comes first - patients with Afib and HF together have significantly worse prognosis.

Learn more about the impact of heart failure and Afib: <a href="https://okt.to/ALk5Hv&quot; target="_blank">https://okt.to/ALk5Hv</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=HeartFailureWeek&highli…; target='_blank'>#HeartFailureWeek</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HeartFailure&highlighte…; target='_blank'>#HeartFailure</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a>

Great few days at <a href="https://twitter.com/hashtag/AFSymposium26.?src=hashtag_click" target="_blank">#AFSymposium26.</a> Together, we discussed the impact of Hybrid AF™ Therapy and the data supporting durable outcomes for patients with advanced Afib. Thank you to everyone who joined us.

Learn more about durable treatment options for your patients:

Great few days at <a href='https://www.linkedin.com/feed/hashtag/?keywords=AFSymposium26.&highligh…; target='_blank'>#AFSymposium26.</a> Together, we discussed the impact of Hybrid AF™ Therapy and the data supporting durable outcomes for patients with advanced Afib. Thank you to everyone who joined us.

Learn more about durable treatment options for your patients: <a href="https://okt.to/C2lLSh&quot; target="_blank">https://okt.to/C2lLSh</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Epeeps&highlightedUpdat…; target='_blank'>#Epeeps</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>

Join us at <a href="https://twitter.com/hashtag/WAFib2026?src=hashtag_click&quot; target="_blank">#WAFib2026</a> to connect with physicians and discuss the AtriClip PRO-Mini® device for minimally invasive LAAE and its role alongside Hybrid AF™ Therapy in treating advanced Afib. See why AtriClip leads globally in LAAE: <a href="https://t.co/3iE1vZq36i&quot; target="_blank">https://t.co/3iE1vZq36i</a&gt;

<a href="https://twitter.com/hashtag/HybridAFTherapy?src=hashtag_click&quot; target="_blank">#HybridAFTherapy</a>

Join us at <a href='https://www.linkedin.com/feed/hashtag/?keywords=WAFib2026.&highlightedU…; target='_blank'>#WAFib2026.</a> At the Western AFib Symposium, we’ll connect with physicians to discuss the latest advancement in left atrial appendage exclusion, the AtriClip PRO-Mini® device for minimally invasive procedures, and its role alongside Hybrid AF™ Therapy in the treatment of advanced Afib.

With a low-profile design built for precision, see why AtriClip continues to lead globally in LAAE: <a href="https://okt.to/hTtKO3&quot; target="_blank">https://okt.to/hTtKO3</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=AtriClip&highlightedUpd…; target='_blank'>#AtriClip</a>

The AtriClip FLEX-Mini® device combines a compact design with exceptional performance for effective LAA exclusion.

Discover the lowest profile surgical LAAM device on the market at: <a href="https://okt.to/aioGyY&quot; target="_blank">https://okt.to/aioGyY</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=AtriClip&highlightedUpd…; target='_blank'>#AtriClip</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=LAAExclusion&highlighte…; target='_blank'>#LAAExclusion</a>

The AtriClip FLEX-Mini® device combines a compact design with exceptional performance for effective LAA exclusion.

Discover the lowest profile surgical LAAM device on the market at: <a href="https://t.co/SXM35UGG8G&quot; target="_blank">https://t.co/SXM35UGG8G</a&gt;

<a href="https://twitter.com/hashtag/AtriClip?src=hashtag_click&quot; target="_blank">#AtriClip</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a> <a href="https://twitter.com/hashtag/LAAExclusion?src=hashtag_click&quot; target="_blank">#LAAExclusion</a>

Are you a recent college graduate looking to start a career in medical device sales? The Sales Training Associate program provides the opportunity to gain clinical proficiency and the business skills necessary to drive business growth.

This 6 to 12-month program establishes a foundation to start your sales career. Learn more at: <a href="https://bit.ly/4rFH5uK&quot; target="_blank">https://bit.ly/4rFH5uK</a&gt;

Without Cryo Nerve Block Therapy, it can take over 40 days to return to mild pain after a thoracic procedure. Discover how you can harness the power of the cryoSPHERE® MAX probe for post-op pain management: <a href="https://okt.to/HIQLeK&quot; target="_blank">https://okt.to/HIQLeK</a&gt;

(Source: <a href="https://okt.to/zscKEo)" target="_blank">https://okt.to/zscKEo)</a>​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=cryoNB&highlightedUpdat…; target='_blank'>#cryoNB</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a>